Utilization of Cell-penetrating Peptide Adaptors to Enhance Delivery of Variably Charged Protein Cargos

This study demonstrates that while intrinsic internalization of positively charged protein cargos is charge-dependent and limited by surface saturation, the efficacy of calcium-dependent cell-penetrating peptide adaptors varies significantly based on cargo charge, with specific adaptor designs capable of overcoming these limits or inhibiting uptake depending on their own electrostatic properties.

The Gist

Imagine your cell is a high-security fortress. The walls (the cell membrane) are designed to keep everything out, including potential life-saving medicines. For decades, scientists have tried to build "Trojan horses" to sneak drugs inside. These Trojan horses are called Cell-Penetrating Peptides (CPPs). They are like sticky, positively charged magnets that latch onto the fortress walls and get pulled inside.

However, there's a major glitch in this plan. Once the Trojan horse enters, it gets stuck in a holding cell called an endosome. Instead of delivering the medicine to the main city (the cytoplasm), the whole package gets locked in the holding cell and eventually destroyed. It's like a delivery driver getting stuck in the lobby and never making it to the apartment.

The New Strategy: The "Detachable" Delivery System

The scientists in this paper, led by Dr. McMurry, came up with a clever workaround. Instead of gluing the medicine (the cargo) permanently to the Trojan horse (the adaptor), they built a smart, temporary connection.

Think of it like a magnetic clasp that holds two things together only when they are in a specific environment (like a specific type of water).

1. Outside the cell: The clasp is strong. The adaptor (Trojan horse) and the cargo (medicine) stick together tightly.
2. Inside the cell: The environment changes (specifically, the "water" becomes less salty). The clasp snaps open.
3. The Result: The Trojan horse gets stuck in the holding cell (which is fine, it's just a decoy), but the medicine is released and free to run to its destination.

The Experiment: Testing Different "Medicines"

The researchers wanted to see how well this system worked with different types of "medicines." They created a series of glowing green proteins (like little glowing balls) that had different levels of positive charge.

• The Old Way (Just the Medicine): They found that if the medicine itself was very positively charged, it could sneak in on its own, but it was slow and inefficient. Also, they discovered a trick: the green glow of the medicine would turn off (go dark) once it got trapped in the acidic holding cell, making it look like nothing had entered. They had to use a special red dye tag to see the truth: A lot of medicine was getting in, but the green light was lying.
• The New Way (Medicine + Adaptor): They tested five different types of "adaptors" (Trojan horses) to see which one was the best delivery driver.

The Results: Who Was the Best Driver?

1. The "Standard" Driver (TAT-CaM): This was their original prototype. It worked great for medicines that were moderately charged, but it was useless for the least charged ones. It was like a delivery driver who only works if the package is already heavy enough to be noticed.
2. The "Super Driver" (TAT-LAH4-CaM): This was the star of the show. This adaptor had an extra "sticky" feature. It grabbed onto every type of medicine, regardless of how charged it was, and dragged them all inside efficiently. It was like a delivery driver with a super-strong magnet who could pick up anything from a feather to a brick.
3. The "Over-Enthusiastic" Drivers (GFP-CaM & TAT-NMR-CaM): These adaptors were designed to be super sticky to the cell surface. While they were good at getting the least charged medicines inside, they actually clogged the door for the highly charged medicines. It was like having a delivery driver who stood in the doorway so firmly that the heavy packages couldn't get through.

The Big Takeaway

The paper teaches us a few important lessons about delivering drugs into cells:

• Charge Matters: Positively charged things naturally want to enter cells, but they often get stuck in the "lobby" (endosomes).
• Don't Trust the Green Light: Just because a glowing drug stops glowing inside the cell doesn't mean it didn't get in; it might just be in a dark room.
• The Perfect Adaptor: The best delivery system isn't just about the "Trojan horse"; it's about how the horse interacts with the specific package. Some adaptors are universal (like TAT-LAH4-CaM), while others are picky.
• The Sweet Spot: There is a limit to how much positive charge helps. Once you hit a certain level, adding more charge doesn't help much. You need a smart adaptor to push past that limit.

In short: The scientists built a smart, detachable delivery system that can sneak different types of drugs into cells. They found that while some drugs can sneak in on their own, a "Super Driver" adaptor can make the process much faster and more reliable, ensuring the medicine actually reaches the inside of the cell where it's needed.

Technical Summary

1. Problem Statement

Cell-penetrating peptides (CPPs) offer a promising non-viral method for delivering biomacromolecular therapeutics into cells. However, a critical bottleneck limits their clinical utility: endosomal entrapment. When CPPs are covalently linked to cargo proteins, they often remain trapped in endosomes along with the cargo, leading to degradation or recycling rather than cytoplasmic delivery.

To address this, the authors previously developed a CPP-adaptor system. This system utilizes a non-covalent, calcium-dependent interaction between a CPP-adaptor (e.g., TAT fused to Calmodulin) and a cargo protein containing a Calmodulin Binding Sequence (CBS). The complex binds to the cell surface and enters via endocytosis. Once inside the endosome, the drop in calcium concentration causes the complex to dissociate, theoretically allowing the cargo to escape into the cytoplasm while the adaptor remains trapped.

The specific knowledge gap addressed in this study: Previous observations suggested that positively charged cargo proteins possess "intrinsic" cell-penetrating properties (acting as Cell-Penetrating Proteins or CPPrs). It was unclear how this intrinsic charge-based internalization interacted with, or masked, the efficacy of CPP-adaptors. The authors sought to systematically investigate the interplay between cargo net charge, concentration, and adaptor efficacy.

2. Methodology

The study employed a sophisticated set of engineered proteins and live-cell imaging techniques:

• Cargo Design: The authors created a series of "supercharged" Green Fluorescent Proteins (GFPs) fused to a CBS and a HiBiT tag. These cargos were engineered with varying net positive charges at pH 7.0: +9, +15, +20, +25, and +36.
  • Redesign: To improve stability and prevent precipitation, the construct order was optimized to His-CBS-GFP-HiBiT (denoted as CGH).
• Adaptors: Five distinct CPP-adaptors were tested:
  1. TAT-CaM: The prototype (TAT peptide + Calmodulin).
  2. TAT-LAH4-CaM: Includes an endolytic peptide (LAH4) sequence.
  3. TAT-AUR-CaM: Includes an endolytic peptide (Aurein 1.2).
  4. TAT-NMR-CaM: Uses naked mole-rat calmodulin with an added positive domain.
  5. GFP-CaM: Uses the +36 supercharged GFP as the sole cell-penetrating element fused to Calmodulin.
• Dual-Labeling Strategy: To distinguish between surface-bound and internalized cargo, the CGH cargos were covalently labeled with DyLight 650 (far-red).
  • Rationale: GFP fluorescence is pH-sensitive and quenched in acidic endosomes (<pH 6.2). The far-red label remains stable. This allows researchers to visualize intracellular cargo as "red" (GFP off, dye on) and surface-bound cargo as "yellow" (GFP on, dye on).
• Experimental Conditions:
  • Cell Line: Baby Hamster Kidney (BHK) cells.
  • Complex Assembly: Adaptors and cargos were pre-mixed in high-salt buffers to prevent precipitation, then diluted into cell media.
  • Imaging: Confocal microscopy (Zeiss LSM 900) was used to capture time-lapse movies and static images (40–70 minute timepoints) to quantify internalization.

3. Key Contributions

• Discovery of Intrinsic Cargo Internalization: The study definitively demonstrates that highly positively charged proteins (like supercharged GFPs) internalize efficiently on their own, often saturating at low concentrations (100–400 nM).
• Methodological Innovation: The development of the dual-fluorophore (GFP + DyLight 650) system to distinguish pH-quenched intracellular cargo from surface-bound cargo without the need for washing steps, which can artifactually remove surface-bound proteins.
• Adaptor Efficacy Mapping: A systematic comparison of how different adaptor chemistries (charge, endolytic sequences) modulate the internalization of cargos with varying intrinsic charges.

4. Key Results

A. Intrinsic Internalization of Cargos

• Charge Dependence: Intrinsic internalization increased with cargo positive charge (+9 to +36).
• Fluorescence Artifact: GFP fluorescence alone grossly underestimated internalization because the acidic endosomal environment quenched the signal. The far-red label revealed that internalization was robust and often saturated at concentrations as low as 100–400 nM.
• Surface Correlation: Intrinsic internalization correlated strongly with surface binding, suggesting that positive charge drives association with negatively charged cell surface proteoglycans.

B. Adaptor Performance

• TAT-CaM (Prototype):
  • Ineffective with low-charge cargos (CGH9, CGH15); it actually inhibited their internalization.
  • Highly Effective with moderately charged cargos (CGH20, CGH25), significantly boosting internalization beyond intrinsic levels.
  • Mechanism: It did not increase surface binding but appeared to stimulate an internalization mechanism for cargos already associated with the membrane.
• TAT-LAH4-CaM:
  • Most Potent Adaptor: It drove maximal internalization for all cargos (from +9 to +36) at low concentrations (100 nM).
  • Mechanism: It strongly recruited all cargos to the cell surface regardless of their intrinsic charge, effectively overcoming the charge barrier.
• GFP-CaM (Supercharged Adaptor):
  • Showed high surface affinity but produced divergent effects. It increased internalization of low-charge cargos (CGH9, CGH15) but inhibited the internalization of highly charged cargos (CGH25, CGH36).
  • At higher concentrations, the complex saturated the surface, preventing internalization.
• TAT-AUR-CaM & TAT-NMR-CaM:
  • Generally showed limited efficacy or inhibition compared to the intrinsic levels, particularly with highly charged cargos.

C. Concentration Dependence

• Intrinsic internalization of supercharged cargos saturates at low concentrations (100–400 nM).
• Adaptors like TAT-CaM and TAT-LAH4-CaM can drive internalization below these saturation limits, suggesting they utilize mechanisms distinct from simple charge-based surface association.

5. Significance and Conclusion

This study fundamentally shifts the understanding of CPP-mediated delivery by highlighting that cargo charge is a dominant variable that can mask or mimic adaptor efficacy.

• Flexibility of Adaptors: The CPP-adaptor system is not a "one-size-fits-all" solution. Different adaptors are required for cargos of different charges. For example, TAT-LAH4-CaM is ideal for neutral or low-charge cargos, while TAT-CaM excels with moderately positive cargos.
• Mechanistic Insight: The data suggests two distinct mechanisms:
  1. Charge-driven surface association: The primary driver for intrinsic internalization of positive proteins.
  2. Adaptor-driven internalization: A secondary mechanism (exhibited by TAT-CaM and TAT-LAH4-CaM) that can enhance uptake even when surface association is low or when intrinsic uptake is saturated.
• Future Directions: The authors conclude that optimizing both internalization (via adaptor selection) and endosomal escape (via the HiBiT/luciferase system mentioned) is critical for developing effective therapeutic delivery strategies. The ability to decouple the CPP function from the cargo allows for the rational design of delivery systems tailored to specific therapeutic protein charges.